Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome
Coreceptor usage of isolates from 30 cynomolgus macaques infected intrarectally (n=22) or intravenously (n=8) with simian immunodeficiency virus of sooty mangabey origin (SIVsm) was evaluated in U87.CD4 and GHOST(3) cell lines. Based on progression rate, the animals were divided into progressors (18 animals), slow progressors (five animals) and long-term non-progressors (seven animals). There was no difference in how many or which coreceptors were used according to route of infection. All isolates but one used CCR5 for cell entry, and CCR5 was also the major coreceptor in 70 out of 105 isolates tested. In general, early isolates were multitropic, using CCR5, CXCR6 and/or gpr15. Interestingly, CXCR4-using viruses could be isolated on human peripheral blood mononuclear cells (PBMCs), but not on cynomolgus macaque PBMCs, suggesting that human PBMCs select for variants with CXCR4 use. Even though CXCR4-using SIV isolates have been reported rarely, we could recover CXCR4-using viruses from 13 monkeys. CXCR4 use either appeared early during the acute phase of infection and disappeared later or only appeared late in infection during immunodeficiency. Surprisingly, one late isolate from a progressor monkey did not use CCR5 at all and used the CXCR4 receptor with high efficiency. The ability to use many different receptors decreased over time in long-term non-progressor monkeys, whilst the majority of progressor monkeys showed broadening of coreceptor use, stable coreceptor use or fluctuation between the different coreceptor-usage patterns. The results indicate that, in the infected host, evolution of SIV coreceptor usage occurs, involving changes in the mode of coreceptor use.
AntonssonL.,
BoketoftA.,
Garzino-DemoA.,
OldeB.,
OwmanC.2003; Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4. AIDS 17:2571–2579[CrossRef]
BjörndalÅ.,
DengH.,
JanssonM.& 7 other authors1997; Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71:7478–7487
BleulC. C.,
WuL.,
HoxieJ. A.,
SpringerT. A.,
MackayC. R.1997; The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A 94:1925–1930[CrossRef]
BrelotA.,
HevekerN.,
PleskoffO.,
SolN.,
AlizonM.1997; Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol 71:4744–4751
ChenZ.,
ZhouP.,
HoD. D.,
LandauN. R.,
MarxP. A.1997; Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 71:2705–2714
CilliersT.,
NhlapoJ.,
CoetzerM.,
OrlovicD.,
KetasT.,
OlsonW. C.,
MooreJ. P.,
TrkolaA.,
MorrisL.2003; The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 77:4449–4456[CrossRef]
DengH. K.,
UnutmazD.,
KewalRamaniV. N.,
LittmanD. R.1997; Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296–300[CrossRef]
DragicT.,
LitwinV.,
AllawayG. P.& 8 other authors1996; HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673[CrossRef]
EdingerA. L.,
AmedeeA.,
MillerK.& 11 other authors1997; Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A 94:4005–4010[CrossRef]
EskildA.,
MagnusP.,
BrekkeT.& 7 other authors1997; The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects. Scand J Infect Dis 29:103–109[CrossRef]
FarzanM.,
ChoeH.,
MartinK.& 10 other authors1997; Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 186:405–411[CrossRef]
FultzP. N.,
McClureH. M.,
AndersonD. C.,
SwensonR. B.,
AnandR.,
SrinivasanA.1986; Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys ( Cercocebus atys
. Proc Natl Acad Sci U S A 83:5286–5290[CrossRef]
HatseS.,
PrincenK.,
GerlachL.-O.,
BridgerG.,
HensonG.,
De ClercqE.,
SchwartzT. W.,
ScholsD.2001; Mutation of Asp171 and Asp262 of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol Pharmacol 60:164–173
HenggeU. R.,
FranzB.,
HoerschS.,
GoosM.2003; Course of HIV disease does not depend on risk group: 7.5-year follow-up in 296 patients. Int J STD AIDS 14:451–457[CrossRef]
HirschV. M.,
SharkeyM. E.,
BrownC. R.& 8 other authors1998; Vpx is required for dissemination and pathogenesis of SIVSM PBj: evidence of macrophage-dependent viral amplification. Nat Med 4:1401–1408[CrossRef]
KarlssonA.,
ParsmyrK.,
SandströmE.,
FenyöE. M.,
AlbertJ.1994; MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin Microbiol 32:364–370
KarlssonI.,
AntonssonL.,
ShiY.& 7 other authors2004; Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype. J Virol 78:11807–11815[CrossRef]
KestlerH.,
KodamaT.,
RinglerD.& 8 other authors1990; Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109–1112[CrossRef]
LabrosseB.,
BrelotA.,
HevekerN.,
SolN.,
ScholsD.,
De ClercqE.,
AlizonM.1998; Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J Virol 72:6381–6388
LaurénA.,
ThorstenssonR.,
FenyöE. M.2006; Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease. J Gen Virol 87:595–606[CrossRef]
LetvinN. L.,
DanielM. D.,
SehgalP. K.& 7 other authors1985; Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71–73[CrossRef]
LiQ.,
DuanL.,
EstesJ. D.& 7 other authors2005; Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148–1152
MäkitaloB.,
BöttigerP.,
BiberfeldG.,
ThorstenssonR.2000; Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge. Vaccine 19:298–307[CrossRef]
MarconL.,
ChoeH.,
MartinK. A.& 7 other authors1997; Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol 71:2522–2527
MarguliesB. J.,
HauerD. A.,
ClementsJ. E.2001; Identification and comparison of eleven rhesus macaque chemokine receptors. AIDS Res Hum Retroviruses 17:981–986[CrossRef]
MattapallilJ. J.,
DouekD. C.,
HillB.,
NishimuraY.,
MartinM.,
RoedererM.2005; Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093–1097[CrossRef]
MengG.,
WeiX.,
WuX.& 9 other authors2002; Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med 8:150–156[CrossRef]
MörnerA.,
BjörndalÅ.,
AlbertJ.,
KewalRamaniV. N.,
LittmanD. R.,
InoueR.,
ThorstenssonR.,
FenyöE. M.,
BjörlingE.1999; Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73:2343–2349
NilssonC.,
ThorstenssonR.,
GilljamG.& 7 other authors1995; Protection against monkey-cell grown cell-free HIV-2 challenge in macaques immunized with native HIV-2 envelope glycoprotein gp125. Vaccine Res 4:165–175
OwenS. M.,
MasciotraS.,
NovembreF.,
YeeJ.,
SwitzerW. M.,
OstyulaM.,
LalR. B.2000; Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells. J Virol 74:5702–5708[CrossRef]
PehrsonP.,
LindbackS.,
LidmanC.,
GainesH.,
GieseckeJ.1997; Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology. AIDS 11:1007–1012[CrossRef]
PöhlmannS.,
StolteN.,
MünchJ.,
Ten HaaftP.,
HeeneyJ. L.,
Stahl-HennigC.,
KirchhoffF.1999; Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J Infect Dis 180:1494–1502[CrossRef]
PrinsM.,
VeugelersP. J.1997; Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study. AIDS 11:621–631[CrossRef]
Quesada-RolanderM.,
MäkitaloB.,
ThorstenssonR.,
ZhangY.-J.,
Castaños-VelezE.,
BiberfeldG.,
PutkonenP.1996; Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses 12:993–999[CrossRef]
RudenseyL. M.,
KimataJ. T.,
BenvenisteR. E.,
OverbaughJ.1995; Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207:528–542[CrossRef]
ScholsD.,
De ClercqE.1998; The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. J Gen Virol 79:2203–2205
SpijkermanI. J.,
KootM.,
PrinsM.,
KeetI. P.,
van den HoekA. J.,
MiedemaF.,
CoutinhoR. A.1995; Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 9:1085–1092[CrossRef]
Stahl-HennigC.,
SteinmanR. M.,
Tenner-RaczK.& 7 other authors1999; Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 285:1261–1265[CrossRef]
StalmeijerE. H. B.,
van RijR. P.,
Boeser-NunninkB.,
VisserJ. A.,
NaardingM. A.,
ScholsD.,
SchuitemakerH.2004; In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists. J Virol 78:2722–2728[CrossRef]
Ten HaaftP.,
VerstrepenB.,
ÜberlaK.,
RosenwirthB.,
HeeneyJ.1998; A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 72:10281–10285
VeazeyR. S.,
DeMariaM.,
ChalifouxL. V.& 7 other authors1998; Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427–431[CrossRef]
VödrösD.,
Tscherning-CasperC.,
NaveaL.,
ScholsD.,
De ClercqE.,
FenyöE. M.2001b; Quantitative evaluation of HIV-1 coreceptor use in the GHOST(3) cell assay. Virology 291:1–11[CrossRef]
VödrösD.,
ThorstenssonR.,
DomsR. W.,
FenyöE. M.,
ReevesJ. D.2003; Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques. Virology 316:17–28[CrossRef]
ZhangL.,
HeT.,
TalalA.,
WangG.,
FrankelS. S.,
HoD. D.1998; In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 72:5035–5045
ZhangZ.-Q.,
SchulerT.,
ZupancicM.& 21 other authors1999; Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286:1353–1357[CrossRef]
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome